CD226 downregulation has been reported in T or NK cells of patients with cancer or human immunodeficiency virus (HIV) [26,43,49,50,96,97,98,99,100,101,102,103], which most likely occurs with an upregulation of PD-1 and TIGIT and impaired functionality. Here, CD226 is linked to cancer.